Literature DB >> 2764549

Biliary and pancreatic excretion of cefamandole.

G P Burns1, T A Stein, M Cohen.   

Abstract

After intravenous infusion of secretin and cholecystokinin in six dogs, cefamandole (50 mg/kg of body weight) was given intravenously for 10 min. Samples of serum, bile, pancreatic juice, liver, pancreas, fat, and muscle were collected over a 2-h period. Cefamandole levels were measured by a microbiological assay. The highest levels were as follows: serum, 160 micrograms/ml; bile, 3,071 micrograms/ml; pancreatic juice, 7 micrograms/ml; liver, 101 micrograms/g; pancreas, 44 micrograms/g; muscle, 20 micrograms/g; and fat, 14 micrograms/g. Levels in pancreatic juice were extremely low compared with levels in pancreatic tissue, suggesting the existence of a barrier to excretion at the ductal membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764549      PMCID: PMC284269          DOI: 10.1128/AAC.33.6.977

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  The effect of verapamil on pancreatic exocrine secretion.

Authors:  G P Burns; M Gersten; S Bank; T A Stein; H M Zimmerman
Journal:  Surgery       Date:  1986-04       Impact factor: 3.982

2.  Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP).

Authors:  E E Ohnhaus; F Halter; G Lebek
Journal:  Endoscopy       Date:  1981-01       Impact factor: 10.093

3.  Biliary concentrations of cefamandole and its use in biliary tract surgery.

Authors:  J U Levi; A S Livingstone; O V Martinez; R Zeppa; T Malinin; D G Hutson; N C Einhorn
Journal:  Scand J Infect Dis Suppl       Date:  1980

4.  Prospective randomized controlled study of prophylaxis with cefamandole in high risk patients undergoing operations upon the biliary tract.

Authors:  M Cáinzos; J Potel; J L Puente
Journal:  Surg Gynecol Obstet       Date:  1985-01

5.  Excretion of cefamandole in the bile.

Authors:  F Lindahl; T B Kjaer; V F Thomsen
Journal:  Scand J Infect Dis Suppl       Date:  1980

6.  Concentration of cefamandole in serum interstitial fluid, bile, and urine.

Authors:  N G Waterman; H U Eickenberg; L Scharfenberger
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Excretion of cephalothin and cefamandole by the normal pancreas and in acute pancreatitis in dogs.

Authors:  J G Studley; J J Schentag; W G Schenk
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

8.  Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.

Authors:  K R Ratzan; H B Baker; I Lauredo
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  Blood-pancreatic juice barrier to antibiotic excretion.

Authors:  G P Burns; T A Stein; L S Kabnick
Journal:  Am J Surg       Date:  1986-02       Impact factor: 2.565

10.  Assessment of pancreatic ductal penetration of antibiotics.

Authors:  J R Wallace; J Johnson; C E Lucas; R Cushing; A M Ledgerwood; C Sugawa
Journal:  Am Surg       Date:  1984-12       Impact factor: 0.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.